Pro- and Anti- Effects of Immunoglobulin A- Producing B Cell in Tumors and Its Triggers. 2021

Ziwen Zhong, and Ke Nan, and Meilin Weng, and Ying Yue, and Wenchang Zhou, and Zhiqiang Wang, and Yiwei Chu, and Ronghua Liu, and Changhong Miao
Department of Anesthesiology, Zhongshan Hospital, Fudan University, Shanghai, China.

B cells are well known as key mediators of humoral immune responses via the production of antibodies. Immunoglobulin A (IgA) is the most abundantly produced antibody isotype and provides the first line of immune protection at mucosal surfaces. However, IgA has long been a divisive molecule with respect to tumor progression. IgA exerts anti- or pro-tumor effect in different tumor types. In this review, we summarize emerging evidence regarding the production and effects of IgA and IgA+ cells in the tumor microenvironment (TME). Moreover, we discuss that the TME cytokines, host diet, microbiome, and metabolites play a pivotal role in controlling the class-switch recombination (CSR) of IgA. The analysis of intratumoral Ig repertoires and determination of metabolites that influence CSR may help establish novel therapeutic targets for the treatment of cancers.

UI MeSH Term Description Entries
D007070 Immunoglobulin A Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions. IgA,IgA Antibody,IgA1,IgA2,Antibody, IgA
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001402 B-Lymphocytes Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation. B-Cells, Lymphocyte,B-Lymphocyte,Bursa-Dependent Lymphocytes,B Cells, Lymphocyte,B Lymphocyte,B Lymphocytes,B-Cell, Lymphocyte,Bursa Dependent Lymphocytes,Bursa-Dependent Lymphocyte,Lymphocyte B-Cell,Lymphocyte B-Cells,Lymphocyte, Bursa-Dependent,Lymphocytes, Bursa-Dependent
D059016 Tumor Microenvironment The milieu surrounding neoplasms consisting of cells, vessels, soluble factors, and molecules, that can influence and be influenced by, the neoplasm's growth. Cancer Microenvironment,Cancer Microenvironments,Microenvironment, Cancer,Microenvironment, Tumor,Microenvironments, Cancer,Microenvironments, Tumor,Tumor Microenvironments

Related Publications

Ziwen Zhong, and Ke Nan, and Meilin Weng, and Ying Yue, and Wenchang Zhou, and Zhiqiang Wang, and Yiwei Chu, and Ronghua Liu, and Changhong Miao
July 1985, The Veterinary clinics of North America. Small animal practice,
Ziwen Zhong, and Ke Nan, and Meilin Weng, and Ying Yue, and Wenchang Zhou, and Zhiqiang Wang, and Yiwei Chu, and Ronghua Liu, and Changhong Miao
January 2022, Frontiers in medicine,
Ziwen Zhong, and Ke Nan, and Meilin Weng, and Ying Yue, and Wenchang Zhou, and Zhiqiang Wang, and Yiwei Chu, and Ronghua Liu, and Changhong Miao
September 1980, Journal of immunology (Baltimore, Md. : 1950),
Ziwen Zhong, and Ke Nan, and Meilin Weng, and Ying Yue, and Wenchang Zhou, and Zhiqiang Wang, and Yiwei Chu, and Ronghua Liu, and Changhong Miao
July 1972, Physiological reviews,
Ziwen Zhong, and Ke Nan, and Meilin Weng, and Ying Yue, and Wenchang Zhou, and Zhiqiang Wang, and Yiwei Chu, and Ronghua Liu, and Changhong Miao
October 2000, International journal of hematology,
Ziwen Zhong, and Ke Nan, and Meilin Weng, and Ying Yue, and Wenchang Zhou, and Zhiqiang Wang, and Yiwei Chu, and Ronghua Liu, and Changhong Miao
April 1996, Nihon rinsho. Japanese journal of clinical medicine,
Ziwen Zhong, and Ke Nan, and Meilin Weng, and Ying Yue, and Wenchang Zhou, and Zhiqiang Wang, and Yiwei Chu, and Ronghua Liu, and Changhong Miao
January 1980, Scandinavian journal of immunology,
Ziwen Zhong, and Ke Nan, and Meilin Weng, and Ying Yue, and Wenchang Zhou, and Zhiqiang Wang, and Yiwei Chu, and Ronghua Liu, and Changhong Miao
June 1996, The Journal of experimental medicine,
Ziwen Zhong, and Ke Nan, and Meilin Weng, and Ying Yue, and Wenchang Zhou, and Zhiqiang Wang, and Yiwei Chu, and Ronghua Liu, and Changhong Miao
January 1977, Review of Czechoslovak medicine,
Ziwen Zhong, and Ke Nan, and Meilin Weng, and Ying Yue, and Wenchang Zhou, and Zhiqiang Wang, and Yiwei Chu, and Ronghua Liu, and Changhong Miao
January 1978, Scandinavian journal of immunology,
Copied contents to your clipboard!